November 09, 2021
Nice & Green participates in the IPO of the French biotech MaaT Pharma now listed on Euronext Paris
Nice & Green, the Swiss investment firm, announces today its participation in the Initial Public Offering (IPO) operation of the French biotech MaaT P...
November 04, 2021
Nice & Green enters a 4-year investment partnership with EEMS Italia SpA which will consolidate its presence in the Energy Transition market by 2026
Nice & Green, the Swiss investment firm, announced today the signing of a 4-year investment agreement of up to EUR 20’450’000 with EEMS Italia SpA (BI...
October 05, 2021
Nice & Green provides funding of 5.4 million euros to Marinomed Biotech AG as part of the plans to advance its scientific and clinical programs
Nice & Green, the Swiss investment firm, announces today the signing of a new investment agreement of up to 5.4 million euros with Marinomed Biotech A...
August 23, 2021
Nice & Green increases its stake in Napster Group PLC to 12.308 % and becomes the largest shareholder
Nice & Green, the Swiss investment firm, is pleased to announce that it has increased its stake in Napster Group PLC, the market leader for music ente...
June 02, 2021
Nice & Green announces the termination of the investment agreement signed with Goodbye Kansas Group (formerly Bublar Group)
Based on mutual understanding between Nice & Green and Goodbye Kansas Group, Nice & Green announces the termination of an investment agreement of up t...
May 14, 2021
Tiscali obtains new funding for implementing its 2021-2023 business plan through an investment agreement with Nice & Green
Tiscali (TIS.MI), the Italian pioneering telecommunications company with the highest fibre coverage available in Italy, has secured a funding commitme...
April 14, 2021
Nice & Green and Napster Group PLC have decided to significantly increase the pace of the financing program.
Napster Group PLC (AIM:NAPS), a leading music company and operator of the MelodyVR and Napster platforms, is pleased to announce that it has secured a...
April 14, 2021
Nice & Green SA is a new member of Swiss Biotech Association for the year 2021
Nice & Green SA is excited to announce its recent membership to Swiss Biotech Association for the year 2021....
March 31, 2021
Nice & Green, a European leading alternative financing company, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael Pieper
Nice & Green SA (“Nice & Green”), an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized list...
February 08, 2021
MelodyVR, a leading music company, announced an investment of £6.48 million by Nice & Green to support the development of its new disruptive app
MelodyVR Group PLC (AIM:MVR), a leading music company and operator of the MelodyVR and Napster platforms, who recently announced its intention to chan...
January 27, 2021
Rapid Nutrition attracts USD 1 million investment with Swiss company Nice & Green to fund its growth strategy
Rapid Nutrition (RAP: SW, OTCQB: RPNRF) a natural healthcare company focused on natural nutrition, diet management and life science products, announce...
January 14, 2021
Cyan Digital Security, one of the world’s leading IT security expert for over 15 years, secures financing line of up to EUR 8.4 million with Nice & Green
The Management Board of cyan AG, a leading globally active provider of intelligent IT security solutions and telecom services, resolved a "Convertible...
January 13, 2021
To finance the acquisition of a manufacturer of implants for spine surgery, Implanet has signed for the fourth time a convertible bond line with its long-term financial partner, Nice & Green
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and...
December 21, 2020
Amoéba, one of the major players in French biotech, renews for the third time a financing line of up to 23 million euros with Nice & Green to support its development
AMOEBA (FR0011051598 - ALMIB), producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product...
December 15, 2020
FacePhi, a world leader in biometric solutions for identity verification, renews its contract with Nice & Green and obtains funding for 20 million euros to enhance its growth plan
The Spanish technology company FacePhi has just concluded a second investment agreement with the Swiss firm Nice & Green worth up to 20 million euros....
December 08, 2020
Evolva, the Swiss biotech company, researching, developing and commercializing nature-based ingredients, has renewed its trust in Nice & Green by securing another CHF 12 million investment
Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of products based on nature, has announced that...
October 28, 2020
Bublar Group enters into financing agreement of up to SEK 50.4 million
Bublar Group enters into a flexible convertible loan agreement with Swiss Nice & Green S.A. of up to SEK 50.4 million. The agreement allows Bublar Gro...
October 04, 2020
Artificial Solutions agrees a flexible convertible notes funding program providing up to SEK 60 million to support accelerated growth
Artificial Solutions® International AB (publ) (“Artificial Solutions”) (SSME:ASAI) the leading specialist in enterprise-strength conversational AI, ha...
August 06, 2020
By signing a EUR 6 million financing agreement with Itway, a high- tech Italian company, Nice & Green confirms its policy to invest in and finance selected small and mid-cap with high potential.
By signing a EUR 6 million financing agreement with Itway, a high- tech Italian company, Nice & Green confirms its policy to invest in and finance sel...
June 29, 2020
Evolva signs a CHF 12 million investment with Swiss company Nice & Green to fund future growth
Evolva (SIX:EVE), the Swiss biotech company, today announced that it has entered into an agreement for the issuance and subscription of convertible no...
June 25, 2020
SpineGuard sécurise un financement en fonds propres de 2,4 M€ sur 12 mois avec Nice & Green
SpineGuard (FR0011464452 – ALSGD, éligible PEA-PME), entreprise innovante qui conçoit, développe et commercialise des dispositifs médicaux destinés à ...
May 18, 2020
WISeKey signs a CHF 10.0 million investment with Swiss investment firm Nice & Green to finance its new IoT Division in Europe and future M&A opportunities
WISeKey signs a CHF 10.0 million investment with Swiss investment firm Nice & Green to finance its new IoT Division in Europe and future M&A opportuni...
March 23, 2020
Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015
Moberg Pharma AB (publ) announces today that the company has entered into a convertible note agreement with Nice & Green S.A. (“N&G”), contingent on a...
September 18, 2019
FacePhi receives a 4 million euros investment from Nice&Green to strengthen its growth
The investment agreement will accelerate the growth of the company, specialized in biometrics for the fintech sector, in the American and Asian market...
July 15, 2019
Morning Note
SpineGuard posted last Thursday Q2 revenues of EUR1.80m (vs EUR1.86m in Q2 2018), down -3%. Currency impact is limited compared to Q1 (-6% on a like-f...
May 09, 2019
Kuros Biosciences enters convertible bond financing agreement for up to CHF 5 million
Kuros Biosciences (SIX: KURN) today announced that it has entered into a convertible bond financing agreement with Nice & Green S.A. for up to a maxim...
November 09, 2018
Implanet met en place avec la société Nice & Green une ligne de financement obligataire incluant un programme d’intéressement
Bordeaux, Boston, le 9 novembre 2018 – 19h00 - IMPLANET, société de technologies médicales spécialisée dans les implants vertébraux et les impla...
September 13, 2018
SpineGuard obtient de nouveaux financements à hauteur de 9 millions d’euros
PARIS et SAN FRANCISCO, le 13 septembre 2018 – 18h00 (CEST) – SpineGuard, entreprise innovante qui conçoit, développe et commercialise des instrumen...
July 26, 2018
AMOEBA ANNONCE LA MISE EN PLACE D’UNE LIGNE DE FINANCEMENT OBLIGATAIRE DE 6 M€ AVEC PROGRAMME D’INTERESSEMENT (OCAPI)
Lyon (France), le 26 juillet 2018 - AMOEBA, producteur d’un biocide biologique capable d’éliminer le risque bactérien dans l’eau a décidé de se do...
June 15, 2018
Onxeo Implements an Equity Line Financing Including an Incentive Program with Nice & Green SA
Paris (France), June 15, 2018 – 6.30 pm CEST - Onxeo S.A., a biotechnology company specializing in the development of innovative drugs in oncology, in...
June 11, 2018
Theraclion met en place un financement en fonds propres de 3,6 M€ sur 12 mois avec NICE & GREEN
Malakoff, le 11 juin 2018 – THERACLION, société spécialisée dans l’équipement médical innovant dédié à l’échothérapie, annonce aujourd'hui ...
December 29, 2017
Saniona Establish Equity Financing of up to SEK 144 million
Saniona AB, a leading biotech company in the field of ion channels, announced today that it has entered into a convertible notes funding agreement wit...
December 01, 2017
Modification du calendrier d’émission de la ligne de financement obligataire de 2,4 M€ avec programme d’intéressement (OCAPI)
PARIS, SAN FRANCISCO, le 1er décembre 2017 – 18h00 CET - SpineGuard, entreprise innovante qui conçoit, développe et commercialise des instruments m...
October 02, 2017
SpineGuard establishes two-year €2.4m Convertible Bonds Facility with Nice & Green
PARIS and SAN FRANCISCO, Oct. 2, 2017 – 6:00 PM CET – SpineGuard, an innovative company that designs, develops, and markets disposable medical devices...